Thiazole substitution of a labile amide bond—a new option toward antiplasmodial pantothenamide-mimics
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.00331-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Xiangning Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia. Hauptthemen laut MEDLINE: Plasmodium falciparum, Antimalarials, Thiazoles, Pantothenic Acid. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research.
Abstract (Originalsprache)
The emergence and spread of artemisinin-partial resistant, malaria-causing Plasmodium falciparum provide the impetus for developing novel antimalarials. Pantothenamides are potent inhibitors of malaria parasite proliferation; however, their clinical use is hindered by pantetheinase-mediated degradation in human serum. Here, we report the synthesis and biological activity of a series of pantothenamide-mimics in which the thiazole ring replaces the labile amide bond with various orientations. Out of 23 novel compounds generated and tested in the presence of pantetheinase, several display sub-micromolar antiplasmodial activity in vitro . A selection of compounds was studied in more detail, and CoA biosynthesis and/or utilization pathways were confirmed to be the target. Toxicity to human cells was not observed. Kinetic studies identified the selected compounds as substrates of the Hs PanK3 enzyme, but with much lower affinity compared to that of the natural substrate pantothenate. The most potent thiazole-bearing antiplasmodial compound was found to bind to Pf PanK with a 120-fold higher affinity compared to Hs PanK, highlighting excellent selectivity, not only against the key first enzyme in the CoA biosynthesis pathway but also at the whole-cell level. In conclusion, thiazole substitution of the labile amide bond represents a promising avenue for developing antimalarial pantothenamide-mimics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia.
- Department of Chemistry, McGill University, Montreal, Québec, Canada.
ORCID-Profile: Karine Auclair, Kevin J Saliba
Förderung
- Canadian Institute of Health Research
Zitieren
APA
Liu, X., Chu, A., Nekouei, M., Lan, C. B., Pierret, A., Auclair, K., & Saliba, K. J. (2025). Thiazole substitution of a labile amide bond—a new option toward antiplasmodial pantothenamide-mimics. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00331-25
Vancouver
Liu X, Chu A, Nekouei M, Lan CB, Pierret A, Auclair K, et al. Thiazole substitution of a labile amide bond—a new option toward antiplasmodial pantothenamide-mimics. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00331-25
BibTeX
@article{Liu2025,
author = {Liu, Xiangning and Chu, Annica and Nekouei, Mina and Lan, Chunling Blue and Pierret, Alexandre and Auclair, Karine and Saliba, Kevin J},
title = {Thiazole substitution of a labile amide bond—a new option toward antiplasmodial pantothenamide-mimics},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.00331-25}
}
EUVIMED